- Docket No.
- 0:24-cv-03043
- District Court
- Minnesota
Goal
- Declaratory judgment and equitable relief
- Enjoin defendants from future violations of ERISA
- Order defendants to make good to the Plan on all losses
- Remove and replace Plan's fiduciaries
- Remove and replace the Plan's PBM
Issues
Litigation Content
Why This Matters
Plaintiffs allege that the defendants’ conduct violates their fiduciary duty under the Employee Retirement Income Security Act to ensure that prescription drug prices under their health benefit plans are reasonable. The mismanagement of health benefit plan funds can contribute to increased health care premiums and out-of-pocket drugs costs, while also constraining employee wage growth.
Potential Impact
Ensuring employers comply with statutory obligations to monitor the cost-effectiveness of various aspects of their health benefit plans could help lower health care costs for employees.
12 Major Filings
- NOTICE OF SUPPLEMENTAL AUTHORITY (Dec 19, 2024)
- MINUTE ENTRY (Dec 17, 2024)
- NOTICE OF SUPPLEMENTAL AUTHORITY (Dec 13, 2024)
- REPLY MEMORANDUM OF LAW IN FURTHER SUPPORT OF DEFENDANT WELLS FARGO & COMPANY’S MOTION TO DISMISS THE CLASS ACTION COMPLAINT (Dec 2, 2024)
- DECLARATION OF TYLER HAYDELL (Nov 8, 2024)
- DECLARATION OF KAI RICHTER (Nov 8, 2024)
- PLAINTIFFS’ MEMORANDUM IN OPPOSITION TO DEFENDANT WELLS FARGO & COMPANY’S MOTION TO DISMISS (Nov 8, 2024)
- CLERK'S NOTICE OF REASSIGNMENT (Oct 28, 2024)
- DECLARATION OF CLARE VERPLANK IN SUPPORT OF MOTION TO DISMISS (Sep 27, 2024)
- DECLARATION OF RUSSELL L. HIRSCHHORN IN SUPPORT OF MOTION TO DISMISS (Sep 27, 2024)
- MEMORANDUM OF LAW IN SUPPORT OF MOTION TO DISMISS (Sep 27, 2024)
- COMPLAINT (Jul 30, 2024)